Biomarkers of cobalamin (vitamin B12) deficiency and its application

被引：0
作者：
W. Chatthanawaree
机构：
[1] Mahidol University,Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital
来源：
The journal of nutrition, health & aging | 2011年 / 15卷
关键词：
Biomarkers; cobalamin deficiency; vitamin B12 deficiency; elderly;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cobalamin (vitamin B12) deficiency in the elderly is an under recognized problem in daily clinical practice. It seems to be important because the deficiency of this vitamin can lead to irreversible neurological damage, anemia, osteoporosis, and cerebrovascular and cardiovascular diseases. Some clinical abnormalities that we thought were related to the normal aging changes may actually be caused by cobalamin deficiency, such as lack of ankle jerk reflex. The prevalence of cobalamin deficiency increases with age (ranges from 0.6% to 46% depending on the population studies and criteria for diagnosis). Other than clinical manifestations, there are some biomarkers for detection of cobalamin deficiency: the red blood cell mean corpuscular volume (MCV); serum cobalamin level; plasma holotranscobalamin; serum methylmalonic acid (MMA) levels and serum homocysteine levels. The interpretation and the application of these biomarkers are here presented.
引用
收藏
页码：227 / 231
页数：4
相关论文
共 127 条
[21]  
Hin H.(2008)Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK Br J Nutr 100 1054-1059
[22]  
Nexo E.(1990)Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations Am J Hematol 34 99-107
[23]  
Hvas A.M.(1994)Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency Am J Med Sci 308 276-283
[24]  
Schneede J.(2005)Novel and established markers of cobalamin deficiency: complementary or exclusive diagnostic strategies Semin Vasc Med 5 140-155
[25]  
Hin H.(2002)Measuring and interpreting holo-transcobalamin(holo-transcobalamin II) Clin Chem 48 407-409
[26]  
Clarke R.(2004)End-stage renal disease increases plasma transcobalamin and neutralizes influence of TCN 776C>G polymorphism Kidney Int 66 2092-2093
[27]  
Sherliker P.(2003)Effect of TCN2 776C>G on vitamin B12 cellular availability in end-stage renal disease patients Kidney Int 64 1095-1100
[28]  
Atoyebi W.(2005)Effects of oral contraceptives and hormone replacement therapy on markers of cobalamin status Clin Chem 51 778-781
[29]  
Emmens K.(2008)Causes and early diagnosis of vitamin B12 deficiency Dtsch Arztebl Int 105 680-685
[30]  
Birks J.(2005)Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999–2000 Am J Clin Nutr 82 442-450
12345678910